EU exit spurs call for deal on radiotherapy

​

Medical isotopes used to treat cancer will be hit by post-Brexit rule changes.

​The UK will need new international agreements to keep its access to radiotherapy for cancer patients when the country withdraws from the EU’s EURATOM nuclear watchdog.

Britain imports all the radioactive medical isotopes used to treat many cancers and they are governed by strict international rules on the transportation of nuclear materials.

Britain’s access to these isotopes is currently assured through its membership of EURATOM, the European nuclear regulator, but the UK government confirmed last month that it would leave the organization as part of its exit from the EU.

To read more please visit https://www.ft.com/content/185175e4-f9cd-11e6-9516-2d969e0d3b65

Source: Financial Times UK